International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 5 , Pages 1588-1597 , 1 April 2008

Virtual HDRSM CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical Observations

  • Donald B. Fuller, M.D.

      Affiliations

    • Radiosurgery Medical Group, Inc., San Diego CyberKnife Center, San Diego, CA
    • Corresponding Author InformationReprint requests to: Donald B. Fuller, M.D., Radiosurgery Medical Group, San Diego CyberKnife Center, 5395 Ruffin Road, Suite 103, San Diego, CA 92123. Tel: (858) 505-4100; Fax: (858) 751-0601
    • ,
  • John Naitoh, M.D.

      Affiliations

    • Coast Urology Medical Group, Inc., La Jolla, CA
    • ,
  • Charles Lee, Ph.D.

      Affiliations

    • Radiosurgery Medical Group, Inc., San Diego CyberKnife Center, San Diego, CA
    • ,
  • Steven Hardy, C.M.D.

      Affiliations

    • Radiosurgery Medical Group, Inc., San Diego CyberKnife Center, San Diego, CA
    • ,
  • Haoran Jin, Ph.D.

      Affiliations

    • Radiosurgery Medical Group, Inc., San Diego CyberKnife Center, San Diego, CA

Received 6 September 2007 ,Revised 18 November 2007 ,Accepted 23 November 2007.

References 

  1. Grills IS, Martinez AA, Hollander M, et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol. 2004;171:1098–1104
  2. Demanes DJ, Rodriguez RR, Schour L, et al. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys. 2005;61:1306–1316
  3. Mate TP, Gottesman JE, Hatton J, et al. High dose-rate afterloading 192Iridium prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys. 1998;41:525–533
  4. Vargas CE, Martinez AA, Boike TP, et al. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a Phase I to II study. Int J Radiat Oncol Biol Phys. 2006;66:416–423
  5. McNeal JE, Redwine EA, Freiha FS, et al. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12:897–906
  6. King CR, Lehmann J, Adler JR, et al. CyberKnife radiotherapy for localized prostate cancer: Rationale and technical feasibility. Technol Cancer Res Treat. 2003;2:25–30
  7. Williams SG, Taylor JMG, Liu N, et al. Estimation of the α/β ratio of prostate cancer using a multivariate analysis of the individual fraction size data of 3756 patients. Int J Radiat Oncol Biol Phys. 2006;66(Suppl.):S10–S11
  8. Demanes D, Altieri G, Barnaba M, et al. High dose rate (HDR) monotherapy is equivalent to combined HDR brachytherapy and external beam radiation therapy (EBRT) for early prostate cancer. [Abstract] Int J Radiat Oncol Biol Phys. 2006;66(Suppl.):S351
  9. Chang SD, Main W, Martin DP, et al. An analysis of the accuracy of the CyberKnife: A robotic frameless stereotactic radiosurgical system. Neurosurgery. 2003;52:140–146discussion, 146–147
  10. Ho AK, Fu D, Cotrutz C, et al. A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Neurosurgery. 2007;60:ONS147–ONS156discussion ONS156
  11. Villers A, McNeal JE, Freiha FS, et al. Invasion of Denonvilliers' fascia in radical prostatectomy specimens. J Urol. 1993;149:793–798
  12. Chao KK, Goldstein NS, Yan D, et al. Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension?. Int J Radiat Oncol Biol Phys. 2006;65:999–1007
  13. Martinez AA, Pataki I, Edmundson G, et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys. 2001;49:61–69
  14. Martin T, Baltas D, Kurek R, et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol. 2004;180:225–232
  15. Yamada Y, Bhatia S, Zaider M, et al. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy. 2006;5:157–164
  16. Akimoto T, Katoh H, Kitamoto Y, et al. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: Impact of rectal dose in high-dose-rate brachytherapy on occurrence of Grade 2 or worse rectal bleeding. Int J Radiat Oncol Biol Phys. 2006;65:364–370
  17. Lotan Y, Stanfield J, Cho LC, et al. Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model. J Urol. 2006;175:1932–1936
  18. Kupelian P, Willoughby T, Mahadevan A, et al. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1088–1098
  19. Bastin KT, Podgorsak MB, Thomadsen BR. The transit dose component of high dose rate brachytherapy: Direct measurements and clinical implications. Int J Radiat Oncol Biol Phys. 1993;26:695–702
  20. Kiffer JD, Schumer WA, Mantle CA, et al. Impact of oedema on implant geometry and dosimetry for temporary high dose rate brachytherapy of the prostate. Australas Radiol. 2003;47:172–176
  21. Hoskin PJ, Bownes PJ, Ostler P, et al. High dose rate afterloading brachytherapy for prostate cancer: Catheter and gland movement between fractions. Radiother Oncol. 2003;68:285–288
  22. Hara W, Patel D, Pawlicki T, et al. Hypofractionated stereotactic radiotherapy for prostate cancer: Early results. Int J Radiat Oncol Biol Phys. 2006;66(Suppl.):S324–S325
  23. Zagars GK, Pollack A. The serum prostate-specific antigen level three months after radiotherapy for prostate cancer: An early indicator of response to treatment. Radiother Oncol. 1994;30:121–127
  24. Blasko JC, Grimm PD, Sylvester JE, et al. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 2000;46:839–850
  25. Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899–905

 Conflict of interest: Dr. Fuller and Dr. Lee received honoraria from Accuray Inc., Sunnyvale, CA, for public speaking.

PII: S0360-3016(07)04756-6

doi: 10.1016/j.ijrobp.2007.11.067

International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 5 , Pages 1588-1597 , 1 April 2008

Article Tools

* Image Usage & Resolution